research use only
Cat.No.S8940
| Related Targets | Adrenergic Receptor Estrogen/progestogen Receptor GPR Androgen Receptor Glucocorticoid Receptor RAAS Progesterone Receptor Opioid Receptor PGES THR |
|---|---|
| Other ACE Inhibitors | DX600 |
|
In vitro |
Water : 86 mg/mL Ethanol : 10 mg/mL
DMSO
: Insoluble
|
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 428.31 | Formula | C19H23Cl2N3O4
|
Storage (From the date of receipt) | 3 years -20°C powder |
|---|---|---|---|---|---|
| CAS No. | 305335-31-3 | -- | Storage of Stock Solutions |
|
|
| Synonyms | N/A | Smiles | CC(C)CC(C(=O)O)NC(CC1=CN=CN1CC2=CC(=CC(=C2)Cl)Cl)C(=O)O | ||
| Targets/IC50/Ki |
ACE2
(Cell-free assay) 0.44 nM
CPDA
(Cell-free assay) 27 μM
|
|---|---|
| In vitro |
In vitro, conversion from angiotensin II to angiotensin-(1–7) by mouse ACE2 is blocked by MLN-4760 (10 μM). This compound inhibits both human and mouse ACE2 activity. In huMNCs, this chemical-B (an isomer of MLN-4760) detects 63% ACE2 with 28-fold selectivity over ACE. In huCD34+ cells, this compound-B detects 38% of ACE2 activity with 63-fold selectivity. In mu-heart and muMNCs, this chemical-B is 100- and 228-fold selective for ACE2, respectively. In muLin- cells, this compound-B detects 25% ACE2 activity with a pIC50 of 6.3. The racemic mixture and this chemical-A shows lower efficacy and poor selectivity for ACE2 in MNCs and mu-heart. |
| In vivo |
MLN-4760 blocks ACE2 activity, thus significantly reverses the elevation of carotid Ang-(1-7) level and the decline of carotid Ang II level induced by NaHS in mice. The anti-atherosclerotic property of NaHS is also significantly abolished by treatment with this compound. |
References |
|
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.